Page last updated: 2024-08-24

triazoles and Nail Fungus

triazoles has been researched along with Nail Fungus in 126 studies

Research

Studies (126)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (2.38)18.2507
2000's10 (7.94)29.6817
2010's89 (70.63)24.3611
2020's24 (19.05)2.80

Authors

AuthorsStudies
Murota, H; Nishimoto, K; Takenaka, M1
Garoufalis, MG1
Gupta, AK; Talukder, M1
Masumoto, A; Matsuda, Y; Nakamura, S; Sugiura, K; Takagi, M; Tatsumi, Y1
Fukushima, S; Higuchi, S; Hiruma, M; Kano, R; Kashiwada-Nakamura, K; Kubo, M; Matsumoto, T; Noguchi, H; Satoh, T; Yaguchi, T1
Kawai, M1
Lin, K; Lipner, SR1
Koo, KT; Lee, BC; Na, J; Pangeni, R; Park, JW1
Kuwano, Y; Sei, Y; Shimoyama, H1
Ahmad Nasrollahi, S; Azizzadeh-Roodpishi, S; Dowlatiy, Y; Ehsani, AH; Fattahi, A; Firooz, A; Ghasemi, Z; Malakooti, S; Naeimifar, A; Samadi, A1
Lipner, SR; Wang, Y1
Hamedani, E; Harkless, L; Navarrete, R; Seun, J; Shofler, D; Thamby, R1
Geizhals, S; Lipner, SR; Wu, AG1
Gupta, AK; Piguet, V; Shear, NH; Venkataraman, M1
Eichenfield, LF; Elewski, B; Guenin, E; Gupta, AK; Pillai, R; Rosen, T; Sugarman, JL; Vlahovic, TC1
Eichenfield, LF; Elewski, B; Guenin, E; Gupta, AK; Pillai, R; Rosen, T; Stein Gold, L; Sugarman, JL; Vlahovic, TC1
Geizhals, S; Lipner, SR1
Cooper, EA; Gupta, AK1
Kasuya, A; Sato, T; Suzuki, T; Yaguchi, T1
Agrawal, V; Mishra, S; Patel, M; Patel, R; Thanki, K1
Akbari, F; Deng, S; Houbraken, J; Najafzadeh, MJ; Naseri, A; Wang, X; Xu, X; Zhang, H; Zhao, R1
Choi, YS; Ho, MJ; Jang, SW; Kang, MJ; Kim, EA; Kim, JS; Park, DW; Park, JS1
Aoi, J; Fukushima, S; Kashiwada-Nakamura, K; Kubo, M; Makino, K; Noguchi, H1
Gupta, AK; Vlahovic, TC1
Abe, M; Fujii, M; Fukuzawa, M; Hattori, N; Iozumi, K; Ito, Y; Kasai, H; Kato, F; Kato, I; Kiryu, H; Kodama, K; Kusuhara, M; Maruyama, R; Mayama, J; Mochizuki, T; Muramoto, F; Nakasu, I; Nishimoto, S; Oh-I, T; Omi, T; Onoduka, T; Seishima, M; Shimoyama, H; Shindo, M; Sugiura, K; Takahashi, H; Takeda, O; Takenaka, M; Tateishi, Y; Tomizawa, K; Tsuboi, R; Uesugi, T; Watanabe, S; Watanabe-Okada, E; Yamamoto, O; Yamanaka, K; Yasuda, H1
Anbalagan, N; Guenin, EP; Gupta, AK; Venkataraman, M1
Abramovits, W; Guenin, EP; Gupta, AK; Venkataraman, M1
Cook-Bolden, FE; Lin, T1
Adigun, CG; Gellings Lowe, N; Hall, SB; Joseph, WS; Rich, P; Vlahovic, TC; Zane, LT1
Hasuko, M; Hirano, H; Inagaki, K; Motoba, K; Shiomi, R; Takahashi, Y; Tsuboi, R1
Ilie, C; Pollak, RA1
Cantrell, W; Elewski, BE; Lin, T1
Imazu, Y; Suzuki, J; Uchida, E; Yamaura, K; Yoneta, Y1
Hayashi, N; Imazu, Y; Suzuki, J; Uchida, E; Yamaura, K; Yoneta, Y1
Ishii, Y; Ito, Y; Matsuki, S; Ogawa, O; Sanpei, K; Schuck, EL; Takeda, K; Uemura, N1
Lipner, SR; Scher, RK3
Baltazar, LM; Costa-Orlandi, CB; Friedman, AJ; Friedman, JM; Mendes-Giannini, MJS; Mordorski, B; Nosanchuk, JD1
Asao, K; Fukushima, S; Hirose, M; Hiruma, M; Ihn, H; Matsumoto, T; Noguchi, H1
Bonhert, K; Dorizas, A; Sadick, NS1
Fukushima, S; Hirose, M; Hiruma, M; Ihn, H; Matsumoto, T; Noguchi, H; Yaguchi, T1
Okubo, A; Tsubouchi, I; Watanabe, S1
Hur, MS; Jung, WH; Lee, YW; Park, M1
Ko, D; Lipner, SR1
Abe, M; Fujii, M; Fukuzawa, M; Hata, Y; Hattori, N; Iozumi, K; Ito, Y; Kasai, H; Katayama, I; Kato, F; Kato, I; Kiryu, H; Kodama, K; Kusuhara, M; Maruyama, R; Mayama, J; Mochizuki, T; Muramoto, F; Nakasu, I; Nishimoto, S; Nomiyama, T; Oh-I, T; Omi, T; Onoduka, T; Sato, T; Sei, Y; Seishima, M; Shimoyama, H; Shindo, M; Sugiura, K; Takahashi, H; Takeda, O; Takenaka, M; Tomizawa, K; Tsuboi, R; Uesugi, T; Watanabe, S; Yamamoto, O; Yamanaka, K; Yasuda, H1
Fukushima, S; Hiruma, M; Ihn, H; Kano, R; Kimura, U; Matsumoto, T; Noguchi, H; Yaguchi, T2
Fata, A; Najafzadeh, MJ; Naseri, A1
Malahias, S; Raterink, K; Sigurgeirsson, B; van Rossem, K1
Rich, P2
Jarratt, M; Kodera, N; Pillai, R; Siu, WJ; Smith, K; Yamakawa, E1
Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J1
Tosti, A1
Dhillon, S; Patel, T1
Lipner, S; Scher, RK1
Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA1
Arakawa, Y; Hosaka, S; Jo Siu, W; Katafuchi-Nagashima, M; Pillai, R; Sugimoto, N; Sugiura, K; Tatsumi, Y1
Gupta, AK; Simpson, FC1
Iwata, A; Katafuchi-Nagashima, M; Kumagai, N; Pillai, R; Sugiura, K; Tatsumi, Y; Watanabe, Y1
Elewski, BE; Gupta, AK; Ieda, C; Kang, R; Kawabata, H; Olin, JT; Pillai, R; Sugarman, JL; Watanabe, S1
Calvarese, B; Glynn, M; Jo, W; Minowa, K; Mutter, L; Nejishima, H; Pillai, R; Sanada, H; Senda, H1
Pollak, RA1
Al-Hatmi, AM; Bonifaz, A; Calderón, L; Curfs-Breuker, I; de Hoog, GS; Meis, JF; van Diepeningen, AD1
Joseph, WS; Vlahovic, TC1
Kawabata, H; Kodera, N; Pillai, R; Sakamoto, M; Sugimoto, N; Tatsumi, Y; Yamakawa, E1
Elewski, BE; Olin, JT; Pillai, R; Pollak, RA1
Kircik, LH1
Bhatia, N; Friedlander, SF; Gupta, AK; Kircik, L; Rosen, T; Stein Gold, L; Zirwas, MJ1
Bhatt, V; Pillai, R1
Canavan, T; Cantrell, W; Elewski, B1
Tatsumi, Y1
Hanafusa, T; Hirohata, A; Ikegami, R; Mabuchi-Kiyohara, E1
Bhatia, N1
Feng, X; Liao, W; Ling, B; Pan, W; Yang, X; Yao, Z1
Gupta, AK; Pillai, R1
Jellinek, NJ; Korotzer, A1
Caldwell, B; Markinson, B1
Rosen, T2
Cohen, J; Joyce, C; Mikailov, A; Mostaghimi, A1
Kanzler, MH1
Chanda, S; Coronado, D; Merchant, T; Vlahovic, TC; Zane, LT1
Cernea, M; Gupta, AK1
Dorval, E; Grace, Y; Machin, JD; Poulakos, M1
Hossin, B; Murdan, S; Rizi, K1
Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A1
Rosen, T; Stein Gold, LF3
Chanda, S; Coronado, D; Del Rosso, J; Zane, LT1
Lagrew, JP1
Elewski, BE1
Hiruma, M; Ihn, H; Kano, R; Matsumoto, T; Noguchi, H2
Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG1
Gupta, AK; Korotzer, A1
Gupta, AK; Studholme, C1
Yamaguchi, H1
Hirayanagi, K; Imai, A; Iwanaga, T; Kubota, N; Miyamae, A; Shibuya, K; Shimamura, T1
Furuya, K; Hoshina, D; Yamaguchi, Y1
Kawada, A; Oiso, N; Tatebayashi, M1
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL1
Kimball, AB; Kumar, S1
Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B1
Beresford, E; Komjathy, S; Krishna, G; Ma, L; Martinho, M; Tavakkol, A; Vickery, D; Yu, X1
Vera-Cabrera, L; Welsh, E; Welsh, O1
Hall, AJ; Kam, JK; Morrissey, O; Szental, JA; Yohendran, J1
Krishna, G; Ma, L; Martinho, M; Prasad, P; Tavakkol, A; Wahl, J1
Ashton, S; Elewski, B; Pollak, R; Rich, P; Schlessinger, J; Tavakkol, A1
Elewski, BE; Ieda, C; Olin, JT; Pariser, DM; Pillai, R; Pollak, R; Ramakrishna, T; Rich, P; Senda, H; Smith, K; Watanabe, S1
Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y1
Bucko, AD; Kawabata, H; Oizumi, N; Olin, JT; Pillai, R; Tschen, EH1
Kakehi, K; Senda, H; Tatsumi, Y; Yokoo, M1
Conetta, B; Gupta, AK; Leonardi, C; Pierce, PF; Stoltz, RR1
Selleslag, D1
Borrego, L; Hernández, J; Hernández-Machín, B; Islas, D; Martín, AM; Peñate, Y1
Loo, DS1
Sellart-Altisent, M; Torres-Rodríguez, JM1
Cárdenes, CD; Carrillo-Muñoz, AJ; del Valle, O; Estivill, D; Giusiano, G; Guardia, C; Guarro, J; Quindós, G; Rodríguez, V1
Dunand, J; Paugam, A1
Chiritescu, ME; Chiritescu, MM; Scher, RK1
Alchorne, MM; Fischman, O; Kaminski, SK; Palmeira, Mdo C; Porro, AM; Yoshioka, MC1
Hernanz Hermosa, JM; Lázaro Ochaita, P1

Reviews

24 review(s) available for triazoles and Nail Fungus

ArticleYear
Efinaconazole in Onychomycosis.
    American journal of clinical dermatology, 2022, Volume: 23, Issue:2

    Topics: Administration, Topical; Adult; Antifungal Agents; Child; Female; Humans; Onychomycosis; Triazoles

2022
Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Medical mycology journal, 2019, Volume: 60, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Humans; Imidazoles; Keratins; Nails; Onychomycosis; Solutions; Triazoles; Trichophyton

2019
A Timeline of Onychomycosis Therapy and Future Directions.
    Skinmed, 2020, Volume: 18, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Humans; Itraconazole; Nail Diseases; Onychomycosis; Terbinafine; Triazoles

2020
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
    Expert review of anti-infective therapy, 2022, Volume: 20, Issue:1

    Topics: Administration, Topical; Adult; Antifungal Agents; Child; Humans; Onychomycosis; Pediatrics; Triazoles

2022
One size does not fit all: the need for individualized treatment based on factors that may affect the therapeutic outcome of efinaconazole 10% solution for the treatment of toenail onychomycosis.
    International journal of dermatology, 2021, Volume: 60, Issue:10

    Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Nails; Onychomycosis; Quality of Life; Treatment Outcome; Triazoles

2021
Onychomycosis: Treatment and prevention of recurrence.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles

2019
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
    Mycoses, 2014, Volume: 57, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole

2014
What is new in fungal pharmacotherapeutics?
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:4

    Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles

2014
The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:7

    Topics: Administration, Topical; Aged; Antifungal Agents; Clinical Trials, Phase III as Topic; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Pharmaceutical Solutions; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; Triazoles

2014
Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Journal of the American Podiatric Medical Association, 2014, Volume: 104, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Onychomycosis; Triazoles

2014
Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:12

    Topics: Administration, Topical; Antifungal Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Humans; Nails; Onychomycosis; Permeability; Triazoles

2014
Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:3

    Topics: Anti-Infective Agents, Local; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Onychomycosis; Pharmaceutical Solutions; Treatment Outcome; Triazoles

2015
[Pharmacological characteristics and clinical results of efinaconazole (Clenafin® Topical Solution 10%), a novel anti-onychomycosis drug].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2015, Volume: 145, Issue:5

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance; Humans; Onychomycosis; Pharmaceutical Solutions; Triazoles

2015
Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:6

    Topics: Administration, Topical; Animals; Antifungal Agents; Foot Dermatoses; Humans; Onychomycosis; Triazoles

2015
Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Cutis, 2015, Volume: 96, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Prospective Studies; Randomized Controlled Trials as Topic; Sex Factors; Treatment Outcome; Triazoles; Young Adult

2015
Efinaconazole and Tavaborole.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:2

    Topics: Administration, Topical; Animals; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Foot Dermatoses; Humans; Microbial Sensitivity Tests; Onychomycosis; Triazoles

2017
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Dermatology online journal, 2016, Mar-16, Volume: 22, Issue:3

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2016
Ungual hyalohyphomycosis caused by Fusarium proliferatum in an immunocompetent patient.
    The Journal of dermatology, 2017, Volume: 44, Issue:1

    Topics: Administration, Topical; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Fusarium; Humans; Hyphae; Naphthalenes; Onychomycosis; Terbinafine; Triazoles

2017
Potential of Ravuconazole and its Prodrugs as the New OralTherapeutics for Onychomycosis.
    Medical mycology journal, 2016, Volume: 57, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Arthrodermataceae; Candida; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Discovery; Humans; Onychomycosis; Prodrugs; Thiazoles; Triazoles

2016
New antifungal therapies for the treatment of onychomycosis.
    Expert opinion on investigational drugs, 2009, Volume: 18, Issue:6

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drugs, Investigational; Foot Dermatoses; Hand Dermatoses; Humans; Microwaves; Onychomycosis; Photochemotherapy; Triazoles

2009
Onychomycosis.
    Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole

2010
Systemic antifungal agents: an update of established and new therapies.
    Advances in dermatology, 2006, Volume: 22

    Topics: Antifungal Agents; Humans; Onychomycosis; Tinea Capitis; Triazoles

2006
Newer systemic antifungal drugs for the treatment of onychomycosis.
    Clinics in podiatric medicine and surgery, 1996, Volume: 13, Issue:4

    Topics: Aged; Antifungal Agents; Child; Enzyme Inhibitors; Female; Griseofulvin; HIV Infections; Humans; Imidazoles; Male; Naphthalenes; Onychomycosis; Terbinafine; Triazoles

1996
[Superficial mycoses in immunosuppressed patients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles

1995

Trials

31 trial(s) available for triazoles and Nail Fungus

ArticleYear
Efinaconazole topical solution 10%: Formulation and efficacy assessment in the treatment of toenail onychomycosis.
    Mycoses, 2020, Volume: 63, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Female; Foot; Humans; Male; Middle Aged; Nail Diseases; Nails; Onychomycosis; Pilot Projects; Triazoles; Young Adult

2020
Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients.
    Clinics in podiatric medicine and surgery, 2020, Volume: 37, Issue:2

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Blood Glucose; Diabetes Complications; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles

2020
Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
    Dermatologic therapy, 2020, Volume: 33, Issue:4

    Topics: Administration, Topical; Adolescent; Antifungal Agents; Child; Foot Dermatoses; Humans; Multicenter Studies as Topic; Onychomycosis; Triazoles

2020
Efinaconazole 10% topical solution for the treatment of onychomycosis in pediatric patients: Open-label phase 4 study.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:4

    Topics: Administration, Cutaneous; Adolescent; Antifungal Agents; Child; Female; Foot Dermatoses; Humans; Male; Onychomycosis; Solutions; Treatment Outcome; Triazoles

2021
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Journal of drugs in dermatology : JDD, 2020, Sep-01, Volume: 19, Issue:9

    Topics: Administration, Topical; Adolescent; Antifungal Agents; Area Under Curve; Child; Female; Follow-Up Studies; Foot Dermatoses; Fungi; Humans; Male; Onychomycosis; Severity of Illness Index; Solutions; Treatment Outcome; Triazoles

2020
Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
    Skin therapy letter, 2021, Volume: 26, Issue:1

    Topics: Administration, Cutaneous; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles

2021
Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole
    Journal of drugs in dermatology : JDD, 2017, 12-01, Volume: 16, Issue:12

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles; Young Adult

2017
Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Journal of drugs in dermatology : JDD, 2018, Feb-01, Volume: 17, Issue:2

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Prognosis; Severity of Illness Index; Treatment Outcome; Triazoles; Young Adult

2018
Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects.
    Clinical and translational science, 2018, Volume: 11, Issue:5

    Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Metabolome; Onychomycosis; Prodrugs; Thiazoles; Triazoles; Young Adult

2018
Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2019, Volume: 21, Issue:3

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Combined Modality Therapy; Female; Follow-Up Studies; Foot Dermatoses; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Onychomycosis; Patient Satisfaction; Photography; Statistics, Nonparametric; Treatment Outcome; Triazoles

2019
Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    The Journal of dermatology, 2018, Volume: 45, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Prodrugs; Thiazoles; Treatment Outcome; Triazoles; Young Adult

2018
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
    The Journal of dermatology, 2019, Volume: 46, Issue:8

    Topics: Administration, Topical; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Foot Dermatoses; Humans; Incidence; Long-Term Care; Male; Middle Aged; Onychomycosis; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles

2019
A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
    Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Quinazolines; Time Factors; Treatment Outcome; Triazoles; Young Adult

2013
Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.
    Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:9

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Ethnicity; Female; Half-Life; Humans; Male; Middle Aged; Nails; Onychomycosis; Pharmaceutical Solutions; Triazoles; Young Adult

2013
Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:10

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Diabetes Mellitus; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles

2014
Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:11

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Drug Delivery Systems; Female; Follow-Up Studies; Foot Dermatoses; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Onychomycosis; Permeability; Triazoles; Trichophyton

2014
Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:11

    Topics: Administration, Topical; Antifungal Agents; Female; Foot Dermatoses; Humans; Male; Middle Aged; Nails; Onychomycosis; Permeability; Treatment Outcome; Triazoles

2014
Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:1

    Topics: Administration, Topical; Adult; Antifungal Agents; Disease Progression; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Prospective Studies; Time Factors; Treatment Outcome; Triazoles

2015
Managing Assessments and Expectations: Patient Responses Following Therapy With Efinaconazole Topical Solution, 10%.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:7

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Nails; Onychomycosis; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; Triazoles; Young Adult

2015
The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:8

    Topics: Administration, Cutaneous; Adult; Aged; Air; Antifungal Agents; Female; Fluorescein; Foot Dermatoses; Humans; Male; Middle Aged; Nails; Onychomycosis; Pharmaceutical Vehicles; Severity of Illness Index; Triazoles

2015
Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:8

    Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Prognosis; Severity of Illness Index; Treatment Outcome; Triazoles; Young Adult

2015
Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Journal of the American Podiatric Medical Association, 2015, Volume: 105, Issue:5

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Onychomycosis; Tinea Pedis; Treatment Outcome; Triazoles; Young Adult

2015
Cost-effectiveness of Confirmatory Testing Before Treatment of Onychomycosis.
    JAMA dermatology, 2016, Volume: 152, Issue:3

    Topics: Administration, Oral; Administration, Topical; Algorithms; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Health Care Costs; Humans; Hydroxides; Naphthalenes; Onychomycosis; Periodic Acid-Schiff Reaction; Potassium Compounds; Potentially Inappropriate Medication List; Terbinafine; Triazoles

2016
A financial perspective on the topical treatment of onychomycosis.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Onychomycosis; Risk Assessment; Treatment Outcome; Triazoles

2016
Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes.
    Journal of drugs in dermatology : JDD, 2016, Oct-01, Volume: 15, Issue:10

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Treatment Outcome; Triazoles; Young Adult

2016
Skin concentrations and pharmacokinetics of posaconazole after oral administration.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Administration, Oral; Adult; Antifungal Agents; Biopsy; Dermatomycoses; Female; Humans; Male; Middle Aged; Onychomycosis; Reference Values; Skin; Triazoles

2010
Determination of posaconazole levels in toenails of adults with onychomycosis following oral treatment with four regimens of posaconazole for 12 or 24 weeks.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nails; Onychomycosis; Treatment Outcome; Triazoles; Young Adult

2011
A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
    The British journal of dermatology, 2012, Volume: 166, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Male; Middle Aged; Naphthalenes; Onychomycosis; Tablets; Terbinafine; Treatment Outcome; Triazoles; Young Adult

2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Triazoles; Young Adult

2013
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:2

    Topics: Administration, Topical; Adult; Antifungal Agents; Chemistry, Pharmaceutical; Double-Blind Method; Female; Humans; Male; Middle Aged; Nails; Onychomycosis; Pharmaceutical Solutions; Research Design; Treatment Outcome; Triazoles; Young Adult

2013
A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Foot Dermatoses; France; Humans; Nails; Ontario; Onychomycosis; Severity of Illness Index; Thiazoles; Treatment Outcome; Triazoles; United States

2005

Other Studies

71 other study(ies) available for triazoles and Nail Fungus

ArticleYear
Chronological evaluation of treatment effect for tinea unguium with efinaconazole: Possibility of an early estimation of treatment effects.
    The Journal of dermatology, 2021, Volume: 48, Issue:12

    Topics: Administration, Topical; Antifungal Agents; Humans; Onychomycosis; Triazoles

2021
Total Dystrophic Onychomycosis Successfully Treated with Efinaconazole Topical Solution in Times of Coronavirus Disease of 2019: A Case Study.
    Journal of the American Podiatric Medical Association, 2022, Apr-27, Volume: 112, Issue:2

    Topics: Administration, Topical; Adult; Antifungal Agents; Coronavirus; Female; Foot Dermatoses; Humans; Onychomycosis; Treatment Outcome; Triazoles

2022
A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
    Journal de mycologie medicale, 2022, Volume: 32, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Humans; Imidazoles; Nails; Onychomycosis; Triazoles

2022
Onychomycosis Caused by Talaromyces muroii Successfully Treated with Efinaconazole.
    Mycopathologia, 2023, Volume: 188, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Onychomycosis; Talaromyces; Triazoles

2023
Modeling of usage and estimation of cost for efinaconazole 10% topical solution in the treatment of onychomycosis.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Drug Costs; Foot Dermatoses; Healthy Volunteers; Humans; Nails; Onychomycosis; Solutions; Triazoles; United States

2020
Preparation and
    Drug delivery, 2019, Volume: 26, Issue:1

    Topics: Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Guinea Pigs; Humans; In Vitro Techniques; Male; Membranes, Artificial; Nails; Onychomycosis; Permeability; Skin; Skin Absorption; Tinea; Triazoles; Trichophyton

2019
Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
    Medical mycology journal, 2019, Volume: 60, Issue:4

    Topics: Administration, Topical; Adult; Aged; Female; Humans; Imidazoles; Male; Middle Aged; Onychomycosis; Retrospective Studies; Solutions; Treatment Outcome; Triazoles

2019
Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Archives of dermatological research, 2020, Volume: 312, Issue:8

    Topics: Administration, Topical; Adverse Drug Reaction Reporting Systems; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Erythema; Humans; Nails; Onychomycosis; Pigmentation; Retrospective Studies; Solutions; Treatment Failure; Triazoles; United States; United States Food and Drug Administration

2020
Retrospective study of factors affecting medication adherence in patients prescribed efinaconazole 10% solution for onychomycosis.
    Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1

    Topics: Administration, Topical; Age Factors; Antifungal Agents; Drug Prescriptions; Humans; Medication Adherence; Onychomycosis; Prescription Fees; Retrospective Studies; Triazoles

2021
A Case of Tinea Faciei, Tinea Corporis, and Tinea Unguium with Dermatophytoma Successfully Treated with Oral Fosravuconazole L-lysine Ethanolate.
    Medical mycology journal, 2021, Volume: 62, Issue:1

    Topics: Administration, Oral; Aged; Arthrodermataceae; Humans; Male; Onychomycosis; Tinea; Treatment Outcome; Triazoles

2021
Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies.
    Colloids and surfaces. B, Biointerfaces, 2021, Volume: 201

    Topics: Antifungal Agents; Arthrodermataceae; Emulsions; Humans; Nails; Onychomycosis; Triazoles

2021
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
    Scientific reports, 2021, 03-24, Volume: 11, Issue:1

    Topics: Antifungal Agents; Aspergillus; Calmodulin; Fungal Proteins; Humans; Iran; Microbial Sensitivity Tests; Nitriles; Onychomycosis; Pyridines; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Tubulin; Voriconazole

2021
Effect of Penetration Enhancers on Toenail Delivery of Efinaconazole from Hydroalcoholic Preparations.
    Molecules (Basel, Switzerland), 2021, Mar-16, Volume: 26, Issue:6

    Topics: Administration, Topical; Animals; Antifungal Agents; Cattle; Diffusion; Drug Carriers; Drug Delivery Systems; Hoof and Claw; Onychomycosis; Permeability; Propylene Glycol; Triazoles

2021
Topical efinaconazole: A sequential combination therapy with oral terbinafine for refractory tinea unguium.
    The Journal of dermatology, 2021, Volume: 48, Issue:9

    Topics: Administration, Topical; Antifungal Agents; Humans; Onychomycosis; Terbinafine; Triazoles

2021
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes.
    The Journal of dermatology, 2021, Volume: 48, Issue:10

    Topics: Administration, Topical; Antifungal Agents; Humans; Onychomycosis; Treatment Outcome; Triazoles

2021
JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
    Skinmed, 2021, Volume: 19, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Child; Foot Dermatoses; Humans; Onychomycosis; Terbinafine; Triazoles

2021
Efinaconazole solution 10% for treatment of toenail onychomycosis in Latino patients.
    Cutis, 2017, Volume: 99, Issue:4

    Topics: Administration, Topical; Antifungal Agents; Female; Foot Dermatoses; Hispanic or Latino; Humans; Male; Middle Aged; Onychomycosis; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; United States

2017
Clinical trial designs for topical antifungal treatments of onychomycosis and implications on clinical practice.
    Cutis, 2017, Volume: 100, Issue:4

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials, Phase III as Topic; Drug Approval; Humans; Onychomycosis; Pyridones; Research Design; Treatment Outcome; Triazoles; United States

2017
[Affinity of Luliconazole for Human Nail Derived Keratin].
    Medical mycology journal, 2017, Volume: 58, Issue:4

    Topics: Humans; Imidazoles; Keratins; Nails; Onychomycosis; Triazoles

2017
[Current Status of Onychomycosis Topical Therapy Conducted at Home].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:5

    Topics: Antifungal Agents; Caregivers; Home Care Services; Humans; Infectious Disease Transmission, Professional-to-Patient; Onychomycosis; Triazoles

2018
[Role of Pharmacists in Topical Therapy for Onychomycosis in the Home-care Setting].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Community Pharmacy Services; Home Care Services; Humans; Japan; Onychomycosis; Patient Compliance; Pharmacists; Prevalence; Professional Role; Quality of Life; Triazoles

2018
Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments.
    Journal of drugs in dermatology : JDD, 2018, Jul-01, Volume: 17, Issue:7

    Topics: Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Nanoparticles; Naphthalenes; Nitric Oxide; Onychomycosis; Permeability; Prescription Fees; Terbinafine; Treatment Outcome; Triazoles; Trichophyton

2018
Topical efinaconazole: A promising therapeutic medication for tinea unguium.
    The Journal of dermatology, 2018, Volume: 45, Issue:10

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Photography; Treatment Outcome; Triazoles

2018
Onychomycosis caused by Aspergillus subramanianii.
    The Journal of dermatology, 2018, Volume: 45, Issue:11

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Female; Foot Dermatoses; Humans; Hyphae; Japan; Microscopy; Onychomycosis; Terbinafine; Triazoles; Young Adult

2018
Evaluation of drug susceptibility test for Efinaconazole compared with conventional antifungal agents.
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Antifungal Agents; Candida albicans; Humans; Microbial Sensitivity Tests; Onychomycosis; Tinea; Triazoles; Trichophyton

2019
Optimizing topical therapy for onychomycosis: the importance of patient education.
    Cutis, 2018, Volume: 102, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Humans; Medication Adherence; Onychomycosis; Patient Education as Topic; Triazoles

2018
Fungal melanonychia caused by Candida parapsilosis successfully treated with oral fosravuconazole.
    The Journal of dermatology, 2019, Volume: 46, Issue:10

    Topics: Administration, Oral; Aged; Antifungal Agents; Candida parapsilosis; Female; Hand Dermatoses; Humans; Melanosis; Onychomycosis; Prodrugs; Thiazoles; Treatment Outcome; Triazoles

2019
Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole.
    The Journal of dermatology, 2019, Volume: 46, Issue:12

    Topics: Aged; Antifungal Agents; Drug Resistance, Fungal; Female; Hand Dermatoses; Humans; Onychomycosis; Terbinafine; Thiazoles; Tinea; Triazoles

2019
First case of Tritirachium oryzae as agent of onychomycosis and its susceptibility to antifungal drugs.
    Mycopathologia, 2013, Volume: 176, Issue:1-2

    Topics: Adult; Antifungal Agents; Basidiomycota; DNA, Fungal; DNA, Ribosomal Spacer; Female; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Molecular Sequence Data; Nails; Onychomycosis; Sequence Analysis, DNA; Triazoles

2013
Topical treatment of onychomycosis with efinaconazole solution 10%.
    Cutis, 2013, Volume: 91, Issue:6

    Topics: Adult; Antifungal Agents; Foot Dermatoses; Humans; Male; Onychomycosis; Triazoles; Trichophyton

2013
Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Cutis, 2013, Volume: 92, Issue:4

    Topics: Administration, Topical; Antifungal Agents; Foot Dermatoses; Humans; Onychomycosis; Recurrence; Triazoles

2013
Efinaconazole: first global approval.
    Drugs, 2013, Volume: 73, Issue:17

    Topics: Administration, Topical; Animals; Antifungal Agents; Drug Approval; Humans; Onychomycosis; Pharmaceutical Solutions; Triazoles

2013
Onychomycosis: current and future therapies.
    Cutis, 2014, Volume: 93, Issue:2

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2014
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Humans; In Vitro Techniques; Keratins; Microbial Sensitivity Tests; Nails; Onychomycosis; Tinea; Triazoles; Trichophyton

2014
Efinaconazole (Jublia) for the treatment of onychomycosis.
    Expert review of anti-infective therapy, 2014, Volume: 12, Issue:7

    Topics: 14-alpha Demethylase Inhibitors; Administration, Topical; Clinical Trials as Topic; Ergosterol; Humans; Microbial Sensitivity Tests; Onychomycosis; Triazoles

2014
In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Administration, Topical; Animals; Antifungal Agents; Colony Count, Microbial; Drug Resistance, Fungal; Guinea Pigs; Microbial Sensitivity Tests; Onychomycosis; Triazoles; Trichophyton

2014
Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment.
    Regulatory toxicology and pharmacology : RTP, 2014, Volume: 70, Issue:1

    Topics: Administration, Cutaneous; Administration, Topical; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; No-Observed-Adverse-Effect Level; Onychomycosis; Pharmaceutical Solutions; Rats; Rats, Sprague-Dawley; Skin; Swine; Swine, Miniature; Time Factors; Triazoles

2014
Efinaconazole topical solution (Jublia) for onychomycosis.
    The Medical letter on drugs and therapeutics, 2014, Sep-15, Volume: 56, Issue:1451

    Topics: Administration, Topical; Antifungal Agents; Drug Approval; Humans; Onychomycosis; Triazoles; United States; United States Food and Drug Administration

2014
Proximal subungual onychomycosis caused by Fusarium falciforme successfully cured with posaconazole.
    The British journal of dermatology, 2015, Volume: 173, Issue:1

    Topics: Antifungal Agents; Foot Dermatoses; Fusariosis; Fusarium; Humans; Male; Middle Aged; Molecular Sequence Data; Onychomycosis; Triazoles

2015
Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:7

    Topics: Administration, Topical; Antifungal Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Foot Dermatoses; Humans; Nail Diseases; Nails; Onychomycosis; Permeability; Pharmaceutical Solutions; Solubility; Triazoles

2015
Management of onychomycosis and co-existing tinea pedis.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Clinical Trials as Topic; Humans; Onychomycosis; Severity of Illness Index; Tinea Pedis; Triazoles

2015
Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution.
    Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5

    Topics: Administration, Topical; Aged; Antifungal Agents; Foot Dermatoses; Humans; Male; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Treatment Outcome; Triazoles

2015
Contact dermatitis caused by efinaconazole solution for treatment of onychomycosis.
    Contact dermatitis, 2015, Volume: 73, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Dermatitis, Allergic Contact; Humans; Male; Middle Aged; Onychomycosis; Patch Tests; Solutions; Triazoles

2015
Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.
    Mycopathologia, 2015, Volume: 180, Issue:5-6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; China; DNA, Fungal; DNA, Ribosomal Spacer; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Onychomycosis; Prevalence; Sequence Analysis, DNA; Triazoles; Young Adult

2015
Reevaluating the Need for Laboratory Testing in the Treatment of Onychomycosis: Safety and Cost-effectiveness Considerations.
    JAMA dermatology, 2016, Volume: 152, Issue:3

    Topics: Cost-Benefit Analysis; Health Care Costs; Humans; Naphthalenes; Onychomycosis; Triazoles

2016
Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.
    Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:1

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Humans; Nails; Onychomycosis; Triazoles

2016
How effective is efinaconazole in the management of onychomycosis?
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:4

    Topics: Antifungal Agents; Disease Management; Humans; Nails; Onychomycosis; Pharmaceutical Solutions; Triazoles

2016
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 102

    Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult

2016
Onychomycosis: Strategies to Minimize Recurrence.
    Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles

2016
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States

2016
Introduction.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Foot Dermatoses; Humans; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles

2016
Using Topical Antifungal Medications: Instructions for patients.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Suppl 3

    Topics: Administration, Cutaneous; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Drug Administration Schedule; Foot Dermatoses; Humans; Onychomycosis; Pyridones; Triazoles

2016
Response to "A financial perspective on the topical treatment of onychomycosis".
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cost-Benefit Analysis; Drug Costs; Female; Foot Dermatoses; Humans; Male; Onychomycosis; Sensitivity and Specificity; Severity of Illness Index; Triazoles

2016
Ungual aspergillosis successfully treated with topical efinaconazole.
    The Journal of dermatology, 2017, Volume: 44, Issue:7

    Topics: Administration, Topical; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Onychomycosis; Triazoles

2017
Tinea and Onychomycosis.
    Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:6 Suppl

    Topics: Administration, Cutaneous; Antifungal Agents; Humans; Imidazoles; Onychomycosis; Recurrence; Tinea; Tinea Pedis; Triazoles

2016
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult

2016
Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Skin therapy letter, 2016, Volume: 21, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Clinical Trials, Phase III as Topic; Humans; Onychomycosis; Solutions; Triazoles

2016
Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis.
    Medical mycology journal, 2016, Volume: 57, Issue:4

    Topics: Administration, Topical; Antifungal Agents; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Fungal; Humans; Imidazoles; In Vitro Techniques; Nails; Onychomycosis; Solutions; Triazoles; Trichophyton

2016
Onychomadesis caused by efinaconazole.
    Contact dermatitis, 2017, Volume: 76, Issue:1

    Topics: Administration, Topical; Aged; Antifungal Agents; Dermatitis, Allergic Contact; Foot Dermatoses; Humans; Male; Nail Diseases; Onychomycosis; Patch Tests; Triazoles

2017
Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet.
    Contact dermatitis, 2017, Volume: 76, Issue:1

    Topics: Administration, Topical; Aged; Antifungal Agents; Dermatitis, Allergic Contact; Foot Dermatoses; Humans; Male; Onychomycosis; Patch Tests; Triazoles

2017
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis

2008
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:6

    Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2010
Presumed Scopulariopsis brevicaulis chorioretinitis in a stem cell transplant recipient.
    Clinical & experimental ophthalmology, 2010, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Ascomycota; Chorioretinitis; Fluorescein Angiography; Humans; Macula Lutea; Male; Mitosporic Fungi; Onychomycosis; Stem Cell Transplantation; Triazoles

2010
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon

2013
Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:12

    Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Male; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis; Triazoles; Trichophyton

2002
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole

2006
[Therapy with voriconazol for a case of chronic mucocutaneous candidiasis].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:10

    Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Multiple, Fungal; Female; Humans; Onychomycosis; Pyrimidines; Triazoles; Voriconazole

2006
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:4

    Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole

2006
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Triazoles; Voriconazole

2007
[In vitro susceptibility of isolates of Scytalidium spp. from superficial lesions against posaconazole].
    Pathologie-biologie, 2008, Volume: 56, Issue:5

    Topics: Antifungal Agents; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Foot Dermatoses; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Onychomycosis; Triazoles

2008
Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome.
    Mycopathologia, 1997, Volume: 137, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Dermatomycoses; Female; Hand Dermatoses; Humans; Male; Microsporum; Onychomycosis; Piperazines; Skin; Triazoles

1997